Friday , September 21 2018
Home / Letter From The Editor / March 19, 2016

March 19, 2016

Mar 19, 2016

daveIf you have read my last two editor’s desks (Issue 824 and DCMS 284) you know that one of my good friends has a nephew diagnosed with type 1 diabetes and all the consternation this has caused the family. Because they live in Raleigh, NC, Joy Pape, our medical editor, and I were able to get the aunt a chance to speak to Dr. John Buse, and she persuaded him to take the young man on as a patient.

If any of you have not heard of Dr. Buse, take it from me he is a legend in diabetes and he is always on the cutting edge of diabetes research. This week, we have the results of a study that his team did comparing long-acting insulin alone to the combination of long-acting insulin with a GLP-1 analog (Item 2). If you take the time to review the results, you will see why this combination is the right choice for many of our patients, and when there is a daily combo shot available, it will have us all thinking in a different direction.


Diabetes Summit 2016

DIC Publisher Steve Freed will be attending the GTCbio 2016 Diabetes Summit, to be held April 25-27, 2016 in Boston, MA.  This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently. Click here for more information.

Free CME Courses
Our web site CME resource is back online! Be sure to check out the new CME courses posted there. Courses are currently available on topics including: Advances in the Medical & Surgical Management of Obesity; Diabetic Retinopathy; Strategies to Improve Prevention and Treatment of Diabetes; and more! Sunday, March 20, 7PM ET

From “An American Idol shares her diabetes challenges on the road to fame, and Jim Turner hits the streets to talk about diabetes fears. Plus, a low carb salad with a sweet and sour twist in the dLife kitchen.” Sundays live online at at 7 PM ET, 6 PM CT, and 4 PM PT. Keep up on the latest dLife news at


We can make a difference!


Dave Joffe, Editor-in-chief